Communiqués Zeo ScientifiX, Inc.

Actions

ZEOX

US68621D2062

Produits pharmaceutiques

Marché Fermé - OTC Markets Autres places de cotation 19:49:34 04/08/2026			Varia. 5j.	Varia. 1 janv.
1,398 ^USD	+4,31%		-15,28%	-48,42%

15/06	Zeo ScientifiX, Inc. publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 avril 2026	CI
09/06	Zeo ScientifiX, Inc. annonce des changements au sein de sa direction	CI

Communiqués

04/08	ZEO ScientifiX Launches First-of-Its-Kind ZEO Xperience, a Three-Day Immersive Regenerative Medicine Experience for Healthcare Professionals	AQ
21/07	ZEO ScientifiX Strengthens South Florida's Growing Biotechnology Ecosystem Through Regenerative Medicine Innovation	AQ
08/07	ZEO ScientifiX Reports Strong Revenue Growth for Three Months and Six Months Ended April 30, 2026	AQ
01/07	ZEO ScientifiX to Host Live Educational Webinar for Healthcare Professionals Exploring the Southeast Regenerative Medicine Revolution	AQ
16/06	ZEO ScientifiX Donates Products to Support Pediatric Burn Reconstruction Mission in Peru	AQ
09/06	ZEO ScientifiX Expands Medical Advisory Board with Leaders in Regenerative and Longevity Medicine	AQ
27/05	ZEO ScientifiX Launches Physician-Led Patient Masterclass Program Following Grassroots Demand in the Southeast	AQ
12/05	ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone.	AQ
21/04	ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians	AQ
09/04	Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX)	AQ
07/04	ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage	AQ
29/01	Zeo ScientifiX : Annual Report for Fiscal Year Ending October 31, 2024 (Form 10-K)	PU
07/01	Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States	PR
12/02/25	ZEO ScientifiX Provides Business Update to Stockholders and the Investment Community	AQ
13/11/24	ZEO SCIENTIFIX : AND EXOTROPIN join forces TO LAUNCH a solution to address the growing unmet need for Hair loss Form 8 K	PU
15/10/24	ZEO SCIENTIFIX : A LEADING SOUTH FLORIDA BIOTECHNOLOGY COMPANY, Launches Regenerative Medicine Educational SERIES FOR PHYSICIANS Form 8 K	PU
30/09/24	Zeo ScientifiX : Material Event Form 8 K	PU
27/11/23	Organicell Regenerative Medicine : Announces 1-for-200 Reverse Stock Split - Form 8-K	PU
09/08/23	Organicell Regenerative Medicine : Acquisition/Asset Disposal - Form 8-K	PU
06/06/23	ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers, Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	AQ
15/05/23	ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
01/05/23	ORGANICELL REGENERATIVE MEDICINE, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
21/04/23	ORGANICELL REGENERATIVE MEDICINE, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	AQ
17/03/23	ORGANICELL REGENERATIVE MEDICINE, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
08/03/23	ORGANICELL REGENERATIVE MEDICINE, INC. : Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)	AQ